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Abstract. The A2 chain of cholera toxin (CTX) contains 
a COOH-terminal Lys-Asp-Glu-Leu (KDEL) se- 
quence. We have, therefore, analyzed by immunofluo- 
rescence and by subcellular fractionation in Vero cells 
whether CTX can be used to demonstrate a retrograde 
transport of KDEL proteins from the Golgi to the ER. 
Immunofluorescence studies reveal that after a pulse 
treatment with CTX, the CTX-A and B subunits (CTX-A 
and CTX-B) reach Golgi-like structures after 15-20 
rain (maximum after 30 min). Between 30 and 90 min, 
CTX-A (but not CTX-B) appear in the intermediate 
compartment and in the ER, whereas the CTX-B are 
translocated to the lysosomes. Subcellular fractionation 
studies confirm these results: after CTX uptake for 15 
min, CTX-A is associated only with endosomal and 
Golgi compartments. After 30 min, a small amount of 
CTX-A appears in the ER in a trypsin-resistant form, 
and after 60 min, a significant amount appears. CTX-A 
seems to be transported mainly in its oxidized form 
(CTX-A1-S-S-CTX-A2) from the Golgi to the ER, where 
it becomes slowly reduced to form free CTX A1 and 
CTX-A2, as indicated by experiments in which cells 
were homogenized 30 and 90 rain after the onset of 
CTX uptake in the presence of N-ethylmaleimide. No- 
codazol applied after accumulation of CTX in the Golgi 
inhibits the appearance of CTX-A in the ER and delays 
the increase of 3', 5'cAMP, indicating the participation 
of microtubules in the retrograde Golgi-ER transport. 
S 
OON  after  the  detection  of  the  COOH-terminal 
KDEL sequence in resident soluble proteins of the 
ER as a retention signal (Munro and Pelham, 1986), 
it became evident that the KDEL sequence is a retrieval 
rather than a retention signal (Munro and Pelham, 1987; 
Pelham, 1989). This view was mainly based on the obser- 
vation that expression of the lysosomal enzyme cathepsin 
D  with a COOH-terminal KDEL sequence led to the re- 
tention of most of the chimeric protein in the ER, but the 
glycan structure of the protein indicated that it had tra- 
versed the cis- and medium-Golgi cisternae before return- 
ing to the ER. Immunofluorescence (Lewis and Pelham, 
1992; Hsu et al., 1992; Tang et al., 1993; SOnnichsen et al., 
1994) and immunoelectronmicroscopical studies (Tang et 
al., 1993; Griffiths et al., 1994) showed that under steady- 
state conditions, the KDEL receptor ERD2 exists mainly 
in Golgi-like structures, particularly in the cis-Golgi net- 
work. The affinity of the KDEL receptor for the KDEL 
motif is increased under the slightly acidic conditions pre- 
vailing in the Golgi cisternae and is decreased under the 
neutral  pH  conditions  in  the  ER  (Wilson  et  al.,  1993). 
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From these observations, it was deduced that: KDEL pro- 
teins can escape from the ER, they are "picked up" by the 
KDEL receptor, they are transported back to the ER to- 
gether with the receptor, and  are finally released in the 
ER. Up to now, however, the manner in which the occu- 
pied KDEL receptor is recycled to the ER remained un- 
clear.  Brefeldin A  (Lippincott-Schwartz et  al.,  1990)  as 
well as overexpression of the KDEL receptor (Hsu et al., 
1992; Townsley et al.,  1993) led to a change in the steady- 
state  distribution  of the KDEL receptor in favor of the 
ER. The overexpression of the secretory protein lysozyme 
fused to a COOH-terminal KDEL signal also resulted in a 
shift in the steady-state distribution of the KDEL receptor 
to the ER. None of these conditions is physiological as in- 
dicated, e.g., by the fact that under these conditions, not 
only the KDEL receptor, but also the Golgi markers man- 
nosidase II and UDP-galactosyl transferase, were translo- 
cated from the Golgi to the ER. 
A  possible  alternative method would be  to channel a 
KDEL protein from the outside of the cell into the Golgi, 
where it might interact with the KDEL receptor and sub- 
sequently become transported to the  intermediate com- 
partment and to the ER. Recently, Miesenb/Sck and Roth- 
man  (1995)  have  presented  such  an  approach  using  a 
KDEL peptide linked to an antibody against c-myc-tagged 
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the  trans-Golgi  network  (TGN)  1 and  the  plasma  mem- 
brane (Luzio et al., 1990). The KDEL peptide contained 
an N-glycosylation consensus sequence and was linked to 
the  antibody by a  disulfide  bridge.  Antibodies  with  the 
linked  KDEL peptide  were  partially translocated  to  the 
TGN, where the peptide could be split from the antibody 
by treating the cells with DTI'. The fact that some of the 
peptide  molecules  became  N-glycosylated indicates  that 
the peptide had indeed reached the ER. The approach re- 
quires  the  expression  of the  TGN-38 fusion protein  and 
treating the cells with DTT. 
We have applied a different approach by making use of 
cholera toxin (CTX), which consists of an isopentameric B 
subunit (CTX-B) (molecular mass of the protomer =  11 kD) 
and a 28.5-kD A  subunit (CTX-A) (Gill, 1976; Mekalanos 
et al., 1983).  The A  subunit is synthesized as a single chain 
but split proteolytically between serine194 and methioninet95 
into the NH2-terminal A1  subunit  (CTX-A1)  (molecular 
mass  =  23  kD)  and  the  COOH-terminal  A2  subunit 
(CTX-A2) (molecular mass =  5.5  kD). Both subunits re- 
main  linked  together  by  a  disulfide  bridge  between 
cysteine187  of  CTX-A1  and  cysteine  5 of  CTX-A2.  CTX 
binds to the  cell surface by interaction  of the  B  subunit 
with the ganglioside GM1. The bound toxin undergoes en- 
docytosis  (Tran  et  al.,  1987;  Sofer  and  Futerman,  1987) 
and reaches the Golgi (Janicot and Desbuquois, 1987; Or- 
landi et al., 1993; Nambiar et al., 1993).  Although binding 
of CTX to the plasma membrane and internalization oc- 
curs  very rapidly,  the  increase  in  cAMP  resulting  from 
ADP ribosylation of G~, by the free A1  subunit of CTX 
does not start earlier than 20-30 min after application of 
the toxin (Orlandi et al., 1993; Nambiar et al., 1993), indi- 
cating  that  it  is  highly  unlikely  that  free  CTX-A1  is  re- 
leased from the CTX during the inital binding of the toxin 
to the plasma membrane. 
Pseudomonas exotoxin, which enters cells also by an en- 
docytotic pathway, becomes considerably more toxic when 
applied as a fusion protein with a COOH-terminal KDEL 
sequence  (Seetharam  et  al.,  1991).  This  effect is  signifi- 
cantly reduced in  the presence of brefeldin A. Similarly, 
the toxicity of the ricin A  chain, which is also taken up by 
an endosomal pathway, is strongly enhanced  (250-fold in 
Vero  cells)  if  it  contains  a  COOH-terminal  KDEL  se- 
quence  (Wales et al.,  1993).  These results could indicate 
that  toxins  entering  the  cells via  an endosomal pathway 
and possessing a  COOH-terminal KDEL sequence inter- 
act with the KDEL receptor in the Golgi and eventually 
reach the ER via retrograde transport. 
Therefore, we have examined whether CTX or its A  sub- 
unit can undergo retrograde transport from the Golgi to the 
ER by means of the COOH-terminal KDEL signal of the 
A  chain. Using CTX with Cy3-1abeled B  subunits and spe- 
cific antibodies directed against the  CTX-B, the  CTX-A, 
and a peptide of CTX-A2, and applying appropriate incu- 
bation and washing techniques, we show here by immuno- 
fluorescence studies and subcellular fractionation experi- 
ments that CTX-B becomes separated from CTX-A either 
1. Abbreviations used in this paper: CTX, cholera toxin; CTX-A, CTX A 
subunit; CTX-A1, CTX A1 subunit; CTX-A2, CTX A2 subunit; CTX-B, 
CTX B subunit; NEM, N-ethylmaleimide. 
before or in  the  Golgi. The released B  subunit  is trans- 
ported  to  the  lysosomes,  whereas  the  released  CTX-A 
chain moves further to the intermediate compartment and 
to the  ER.  These results suggest  the  possibility of using 
CTX for studying the retrograde transport of the KDEL 
proteins from the Golgi to the ER and factors regulating 
this  transport.  Using  this  approach,  we  can  show  that 
treatment of Vero cells with nocodazol, given after arrival 
of CTX  in  the  Golgi,  strongly  inhibits  the  transport  of 
CTX-A from the Golgi to the ER and significantly delays 
the increase of cAMP. 
Materials and Methods 
Materials 
CTX and CTX-A subunit were obtained from List Biologicals (Camp- 
bell, CA). CTX-B was purchased  from Calbiochem  (La Jolla, CA) and 
Sigma  (Munich,  Germany).  The  ganglioside  GM1  (bovine  brain)  was 
from RBI, Natick, MA), nocodazol was from Sigma, and NHS-LC-biotin 
was from Pierce  Chemical Co. (Rockford,  IL). UDP-[3H]galactose was 
obtained from Amersham-Buchler  (Braunschweig, Germany).  CTX and 
an anti--CTX-A2 antibody were labeled at room temperature for 30 min 
with a 10-fold molar excess of the sulfoindocyanine dyes Cy3 and Cy5, re- 
spectively (Biological Detection Systems, Pittsburgh,  PA). Under the la- 
beling conditions used, only the B subunits of CTX became labeled (Fig. 
1). All other reagents of analytical grade were from Boehringer Mann- 
heim GmbH (Mannheim, Germany), Merck (Darmstadt,  Germany), Bio- 
mol (Ilvesheim, Germany), or Serva (Heidelberg, Germany). The peptide 
NHrKRQIFSGYQSDIDTHNRI-COOH from cholera toxin  A2 chain 
and the peptide NH2-CLYITKVLKGKKLSLPA-COOH, representing the 
COOH terminus of the KDEL receptor ERD2 plus an NH2-terminal cys- 
teine, were synthesized by B. Schmidt (Department of Biochemistry, Uni- 
versity of G6ttingen). 
Antibodies 
Polyclonal antibodies  against  CTX-B were raised  in rabbits,  polyclonal 
antibodies against CTX-A, CTX-A1, and against a peptide of the CTX-A2 
subunit were raised in guinea pigs and rabbits. The guinea pig antibodies 
Figure 1.  Exclusive labeling of the CTX-B subunits  after the re- 
action  of holo-CTX with  the succinimide  ester of the sulfoin- 
docyanine dye Cy3. (Left panel) Coomassie blue staining, ml and 
rn  2, high and low molecular weight markers, respectively;  CTX, 
CTX subunits  A1, B, and A2 (reducing  gel). (Right panel) Cy3- 
labeled CTX was separated by reducing  and nonreducing  SDS- 
PAGE, and the fluorescence  of the chromatogram was recorded 
using a long-pass 590-nm filter (Schott)  and an excitation  wave- 
length of 514 nm. Note that fluorescence  is associated  only with 
CTX-B (reducing gel) or with the holo-toxin  (nonreducing  gel), 
but not with CTX-A. Under nonreducing  conditions, the samples 
containing  SDS were not heated.  Under these conditions,  the 
holo-toxin  (CTX) did not dissociate. Cy3-1abeled CTX-B there- 
fore appears (right panel) with  an apparent molecular mass of 
,-~84 kD. 
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rose (Pharmacia, Freiburg, Germany) and affinity purified on a CTX-A2 
peptide column. Antibodies against CI'X-B were preadsorbed with CI'X-A. 
Rabbit polyclonal antibodies against the COOH terminus of ERD2, cat- 
reticulin, and against the COOH-terrmnal tetrapeptide KDEL were a kind 
gift from Dr. Nguyen Van (Abtlg. Kiln. Biochemie, Univ. of Grttingen), rab- 
bit and goat polyclonal antibodies against cathepsin D were a kind gift from 
Dr. A. Hille-Rehfeld (Department of Biochemistry, University of GSttin- 
gen). The mAbs against the intermediate compartment marker p53 (ERGIC- 
53) and the Golgi marker giantin were kindly provided by Dr. H.P. Hauri 
(Biozentrum, University of Basel, Basel, Switzerland). An antibody against 
a-tubulin was obtained from Sigma. Secondary antibodies labeled with 
F1TC or tetramethylrhodamine came from Dianova (Hamburg, Germany). 
Immunofluorescence Studies 
Veto ceils were grown on uncoated coverslips to confluency. The ceils 
were washed with PBS to remove the serum and incubated for 20 rain at 
0°C with 1 ~M ganglioside GM1 dissolved in DME without FCS. After 
prebinding of GM1, the medium was removed and the culture dishes were 
placed on a thick metal plate that bad been cooled to 0°C. The cells were 
then incubated for 20 min at 0°C with FCS-free DME containing 0.1 ixg/ml 
of CTX or Cy3-1abeled CTX (only B subunit labeled) to allow binding of 
the  toxin  to  the  plasma  membranes.  Subsequently,  the  sample  was 
warmed for 5 rain to 37~C to start internalization of CTX. To remove as 
much free CTX as possible, the cells were rapidly washed three times with 
PBS containing 1 ~M ganglioside GM1. After the addition of DME with 
10%  FCS,  the incubation was continued in an incubator (5%  CO2)  at 
37~C. At the time points indicated, the coverslips were removed and the 
cells were fixed in 0.2% glutaraldehyde/2%  paraformaldehyde for 10 rain 
on ice and for 20 rain at room temperature to prevent toxin translocation 
during fixation. Free aldehyde groups were blocked with 50 mM NI~CI 
followed by permeabilization with I).15%  (wt/vol) saponine in blocking 
medium (PBS/0.2%  (wt/vol)  gelatin). This was fo)/owed by incubation 
with the first antibody for 30 min at 37°C in the prrsence of blocking me- 
dium. After washing and incubation with the second antibody for 30 rain 
at room temperature, cells were mounted in Moviol 4-88 (Hoechst, Frank- 
fuel, Germany) and dried overflight. Epifluoreseence  was detected using 
an Axiovert microscope (Carl Zeiss, Inc., Thormwood, NY) with a Plan- 
Neofluar ×100/1.30 objective. When Cy3-1abeled CI~ was used, ceils were 
treated and fixed in the same way, but the time-dependent changes in the dis- 
tribution of CTX-B were followed by directly measuring Cy3-fluorescence. 
In the experiments where nocodazol was used, the cells were first incu- 
bated with 0.1 p.g/ml CTX for 30 rain as described above to allow for accu- 
mulation of CTX in the Golgi. 10 p.g/ml nocodazol (final concentration) 
was then added, and the incubation continued for the indicated times~ fol- 
lowed by fixation and immunofluorescence analysis as described above. 
SubeeUular Fractionation 
Incubation of Vero cells with CTX was performed as described above for 
the immunotluorescence studies, except that the cells were grown to 90% 
confiuency in 145-cm  z plastic petri dishes (Greiner, NUrtingen, Germany) 
in DME/10% FCS. The pretreatment with GM1 and the incubation with 
CTX were  performed as described  above for the immunofluorescence 
studies, except that the concentration of CTX was 0.5 p.g/ml. At the time 
points given in the figure legends, the dishes were cooled on ice, the me- 
dium was removed, and the ceils were washed with ice-cold PBS. The cells 
were removed with a rubber policeman in the presence of removing me- 
dium (140 mM NaCI, 25 mM Tris-HC1, 30 mM KCI, 10 mM EDTA, pH 
7.4).  After the replacement of the removing medium by homogenization 
medium (130 mM KCI, 25 mM NaCI, 25 mM Tris, I mM EGTA), the cells 
were homogenized by pushing them three times each through 22G, 24G, 
and 27G injection needles, respectively. The homogenates were spun for 
10 rain at 1,000 g. The supernatant was spun for 10 min at 3,000 g, and the 
resulting supernatant was layered on top of a step gradient consisting of 
1 ml each of 30, 25, 20, 15, 12.5,  10, 7.5, 5 and 2.5% (vol/vol) iodixanol in 
homogenization buffer. After centrifugation at 126,000 g~v for 25 rain (SW 
40.1 rotor; Beckman Instruments, Palo Alto, CA), I0 fractions were col- 
lected  from the  top  of the  gradient  and  analyzed  for  density, protein 
(Bradford,  1976),  as well as the enzymatic activities of UDP-galactosyl- 
transferase (Verdon and Berger, 1983), rotenone-insensitive NADH-cyto- 
chrome C reductase (Sottocasa et al., I967), and [3-hexosaminidase (Hall 
et al., 1978).  To separate the particulate fractions from soluble proteins, 
0.5 ml of each fraction was diluted with PBS and spun for 2 h at 100,000 gay- 
The resulting sediments were dissolved in Laemmli mix (Laemmli, 1970) 
under nonreducing or reducing (50 mM 2-mercaptoethanol plus 50 mM 
DTr) conditions and analyzed by SDS-PAGE (16%  gels) using a  mul- 
fiphasic buffer system according to the method of Wiltfang et aL (1991) to 
detect free CTX-A2. Only the samples processed under reducing condi- 
tions were heated in the Laemmli mix before electrophoresis. In some ex- 
periments, the homogenization medium contained 5 mM NEM to alkylate 
GSH and other sulfhydryl metabolites that could potentially lead to a 
cleavage of the CTX-A-sulfhydryl bridge, 
Biotinylation of Plasma Membranes 
CTX uptake was started as described above for the subcellular fraction- 
ation studies. 60 rain after the initiation of CTX uptake, the ceils were 
cooled on ice, washed with ice-cold PBS, and incubated for 10 rain at 0~C 
with 0.1 mg/ml NHS-LC-biotin in PBS. Then the medium was removed, 
and remaining reactive NHS-LC-biotin was blocked by addition of 100 mM 
Tris-Cl, pH 8. The ceils were subsequently homogenized and fractionated 
by iodixanol density gradient centrifugation as described above. Aliquots 
of the fractions were diluted and spun for I h at 100,000gay. The sediments 
were processed by SDS-PAGE and immunoblotting using streptavidin- 
peroxidase for detection. 
Trypsin Digestion 
Ceils were allowed to take up CTX as described above for 120 rain. They 
were then homogenized and separated by iodixanol gradient centrifuga- 
lion as described. The fractions containing the peak concentrations of cal- 
reticulin and CTX-A were diluted and sedimented by centrifugation for 2 h 
at 100,000 g. The sediment was resuspended in 130 mM KCI, 20 mM NaC1, 
20 mM sucrose, 25 mM Hepes NaOH, 1 mM Mg acetate, pH 7.4 (medium R) 
containing 1 mM tetracaine for membrane stabilization.  After another 
centrifugation, the sediments were again resuspended in medium R  and 
incubated for 10 rain at 30°(2 without further addition, or with 30 ~g/ml 
trypsin in the absence or presence of 1% (vol/vol) Triton X-100. The sam- 
ples were suspended in Laemmli mix without reducing agents and were 
analyzed without previous heating by nonreducing SDS-PAGE. 
Determination of  3', 5'-cAMP 
cAMP was measured by an ELISA according to the recommendations of 
the manufacturer (Amersham-Buchler  Co.; code RPN 225). 
Results 
lmmunofluorescence Studies with Complete 
Cholera Toxin 
To exclude the possibility that the uptake of CTX was lim- 
ited by the number of binding sites in the pIasma mem- 
branes, the cells had been preincubated with the ganglio- 
side GM1. Since the main goal of the present studies was the 
transport of CTX within the retrograde secretory pathway, 
it was not studied whether the preincubation with  GM1 
accelerated or increased the cAMP response. The washing 
of the cells with a medium containing GM1 after binding 
and short internalization of CTX proved to be important 
for obtaining a clear time-dependent movement of CTX 
subunits through the different intracellular compartments. 
After 5-10  min  of incubation  with  CTX  at  37°C,  the 
toxin (A and B  subunits) can be observed in association 
with plasma membranes (Fig. 2, a and b). At this time, im- 
munopositive small vesicular structures and early staining 
of Golgi-like structures are also found (Fig. 2 a). After 20- 
30 rain, a distinct accumulation of CTX-A (Fig. 2 c) in the 
Golgi occurs, as indicated by the colocalization with the 
ERD2 protein (Fig. 2, c and d). At this time, a colocaliza- 
tion of CTX-A with the ER marker calreticulin is hardly 
detectable (Fig. 3, a-c). If the incubation is extended fur- 
Majoul et al. Golgi-ER Transport of Cholera Toxin A Subunit  779 Figure 2.  Time-dependent intracellular transport of CTX-A. After 10 min of uptake, significant portions of CTX-A and CTX-B are still 
associated with the plasma membrane, as detected by the fluorescence of the Cy3-1abeled B-subunit (a) or by a Cy5 labeled anti-CTX- 
A-directed antibody (b). After 30 rain, most of the toxin (as detected with the anti-CTX-A2 peptide antibody) has accumulated in 
Golgi-like structures (c), as indicated by the coloealization with the KDEL receptor ERD-2 (d). 45 rain after initiation of CTX uptake, 
CTX-A was no longer restricted to Golgi-like structures (e), but it partially coloealized with the ERGIC marker p53 (f). Note that a and 
b represent confocal laser scan images. Bar, 10 ~zm. 
The Journal  of Cell Biology,  Volume 133, 1996  780 Figure 3.  Time-dependent translocation of CTX-A from the Golgi to the ER. CTX-A (a), calreticulin (b), and an overlay (c) of a and b 
30 min after the initiation  of CTX uptake. CTX-A (d), calreticulin  (e), and an overlay 09 of d and e 90 min after the initiation  of CTX 
uptake. Laser scan double immunofluorescence.  Bar, 10 Ixm. 
ther,  the  CTX-A subunit,  as  assessed with  the  CTX-A2 
peptide-specific antibody, starts to leave the Golgi, as can 
be deduced from the more extended distribution of CTX-A 
(Fig.  2  e)  and  a  decreasing  colocalization  with  ERD2 
(results  not  shown here).  At this  stage, CTX-A partially 
colocalizes with p53, a  marker for the intermediate com- 
partment (Schweizer et al.,  1988)  (Fig. 2, e  and f). After 
60-90 min, most of the CTX-A appears in a reticular struc- 
ture that colocalizes with the ER marker calreticulin (Fig. 
3, d-C). 
During the early phase of CTX uptake, the transport of 
the B subunit parallels that of the A  subunit. 10 rain after 
initiation of uptake, CTX-B is observed on the plasma mem- 
brane and in punctuated structures that most likely repre- 
sent endosomes (Fig. 4 a). At 20 min, CTX-B starts to ac- 
cumulate in perinuclear structures  (Fig. 4  b).  At 30 min, 
significant  amounts  of CTX-B  colocalize with  the  Golgi 
marker giantin (Linstedt and Hauri, 1993) (Fig. 4, c and d), 
but CTX-B appears also in punctuated structures scattered 
throughout  the cell  (Fig. 4  c).  At 90 min, when CTX-A 
exhibits a  reticular distribution  (Fig. 3,  d-f), CTX-B still 
resides to a large extent in perinuclear compartments (Fig. 
4 e), but also in more punctuated structures that colocalize 
with the lysosomal marker cathepsin D  (Fig. 4 3'). Clearly, 
CTX-A does not colocalize with cathepsin D  (Fig. 4, g and 
h). Thus, it appears that CTX-A and CTX-B become sepa- 
rated in the late endosomes or the TGN, from where the 
A  subunits  are further translocated via retrograde trans- 
port to the ER while B subunits are channeled into the ly- 
sosomes. 
SubceUular Fractionation 
The distribution of marker enzymes after iodixanol gradi- 
ent centrifugation of the 3,000-g supernatant shows a rea- 
sonable separation of the Golgi fractions (as represented 
by UDP-galactosyltransferase) from the ER fractions (as 
represented  by rotenone-insensitive  NADH  cytochrome 
C  reductase)  and calreticulin  (Figs. 5  and 6).  Fractions 8 
and 9 containing most of the ER markers were almost free 
of contamination  with  lysosomes. Fractions  8  and  9  to- 
gether contained only ,-~2.5% of total N-acetylhexosamini- 
dase activity. Most of the  [3-hexosaminidase activity was 
found  in  the  pellet  fraction,  and  some  activity was  also 
found in the three top fractions of the gradient. The bio- 
tinylation  experiments  indicate  further  that  the  plasma 
membrane fractions band in the three to four top fractions 
of the  gradient,  and  that  the  fractions representing  ER, 
indicated by the distribution  of the KDEL protein calre- 
ticulin, are free of contaminating plasma membranes (Fig. 
6).  The last two lanes in Fig.  6  also show that when the 
1,000 g supernatant was subsequently centrifuged at 3,000 g, 
a large amount of biotinylated material could still be sedi- 
mented. This material, which to a large extent represents 
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Figure 5.  Distribution of mark- 
er enzymes. Distribution of the 
Golgi marker UDP-galactosytrans- 
ferase  (UDP-GAL-TRANSF, 
black columns) and the ER mark- 
er rotenone-insensitive  NADH- 
cytochrome C reductase (RICCR, 
hatched columns) after iodixanol 
gradient  equilibrium  density 
centrifugation  of a  3,000-g su- 
pernatant  of  a  homogenate 
from Vero cells. Open triangles, 
protein concentration;  open  cir- 
cles,  gradient  density.  The  en- 
zyme activities are expressed as 
relative activities taking the frac- 
tion with the highest total activi- 
ty as 1. 
"sheet"-like plasma membranes produced by shear force 
during cell disruption, had to be removed before gradient 
centrifugation to yield ER fractions free of plasma mem- 
branes. 
Cells were analyzed 15 and 60 min after initiation of up- 
take of CTX for the distribution of CTX-A in the gradient 
by using the anti-CTX-A2 peptide antibody (Fig. 7). After 
15 min, CTX-A appears in a nonreducing gel with an ap- 
parent molecular mass of ~28.5 kD and mainly in the first 
four to five fractions representing plasma membranes, en- 
dosomes, and Golgi (Fig. 7 a). Clearly, the ER fractions, as 
represented  by  the  distribution  of  rotenone-insensitive 
NADH cytochrome C reductase, are almost free of detect- 
able amounts of CTX-A. At 60 rain, however, the nonre- 
ducing gel shows CTX-A distributed all over the gradient 
with maxima in fractions 3-5 and fractions 8 and 9 (Fig. 7 
b). It runs with an apparent molecular mass of ~28.5 kD, 
indicating that even the ER contains unsplit CTX-A. Un- 
der the  same conditions,  the  CTX-B  remains associated 
mainly with the uppermost four fractions of the gradient 
and does not appear in the ER fractions (Fig. 7 c). 
In contrast to the experiments shown in Fig. 7, where an 
antibody  directed  against  a  peptide  from  CTX-A2  was 
used, the antibody used in the experiments shown in Figs. 
8 and 9 reacted with CTX-A as well as with CTX-A1 and 
CTX-A2. Fig. 8 indicates that 120 min after the beginning 
of CTX uptake, free CFX-A1 and CTX-A2 existed in the 
ER. To exclude the possibility that this reflects an artifact 
resulting from the leakage of sulfhydryl metabolites (e.g., 
reduced  glutathione,  cysteine,  cysteamine)  into  the  ER 
during  the  homogenization  and  fractionation  procedure, 
we have performed experiments in which the homogeniza- 
tion medium contained 5 mM NEM (Fig. 9). The experi- 
ments were otherwise  performed as described  in Fig.  7. 
The fractions were analyzed by nonreducing SDS-PAGE 
and  immunoblotting  using  the  antibody  applied  also  in 
Fig.  8.  After CTX uptake for 30 min,  CTX-A,  but  only 
traces of CTX-A1, could be detected mainly in the Golgi 
fractions. Some CTX-A had already reached the ER (as 
indicated  by the  position  of calreticulin  in  the  gradient, 
Fig. 9 a), but CTX-A1 could not be detected in this com- 
partment (Fig. 9 b). After 90 min, a considerable portion 
of CTX-A had moved to the ER fractions, now accompa- 
nied by CTX-A1 as well as by CTX-A2 (Fig. 9 c). The mi- 
nor amounts of sedimentable CTX-A1 and CTX-A2 in the 
upper fractions most likely resulted from smaller vesicles 
generated from broken ER cisternae, as indicated by the 
traces  of calreticulin  (Fig.  9  a)  migrating with  the  same 
Figure 4.  Experiments with CTX containing Cy3-1abeled B subunits: CTX-B does not enter the ER but is directed to the lysosomes. (a- 
c) Distribution 10, 20, and 30 min after the beginning of CTX uptake, respectively. In d, the cells shown in c were double-stained  for the 
Golgi marker giantin. A comparison of the distribution  of CTX-B at 90 rain after initiation of CTX uptake (e) with that of cathepsin D 
(f) indicates that at this time point, a significant portion of CTX-B had reached the lysosomes. At the same time point, CTX-A (as as- 
sessed with a CTX-A2 peptide antibody preadsorbed with CTX-B; Fig. 4 g) showed little colocalization with cathepsin D (Fig. 4 h), but 
was mainly distributed  in reticular structures most likely representing ER (compare with Fig. 3). Bar, 10 I~m. 
Majoul et al. Golgi-ER Transport of Cholera Toxin A Subunit  783 Figure 6.  Distribution of biotinylated proteins in the iodixanol 
gradient. Vero cells were labeled with biotin at 0°C for 10 min 
and homogenized as described in the methods section. The ho- 
mogenate was spun at 1,000 gav for 10 min, and the supernatant 
was centrifuged again for 10 min at 3,000 gay. The 3,000-g super- 
natant was loaded onto an iodixanol gradient and spun for 25 min 
at 126,000 gay as described in Fig. 6. The fractions were diluted, 
sedimented by centrifugation at 100,000 gmax for 60 min, and the 
pellets were analyzed by SDS-PAGE. After blotting, biotinylated 
proteins were detected with streptavidin-peroxidase (a). Lanes A 
and B represent the 3,000-g and 1,000-g sediments, respectively. 
Note that the 3,000-g sediment still contains significant amounts 
of biotinylated proteins. (b) The distribution of the ER marker 
calreticulin. Note that some calreticulin moves with the lighter 
fraction. This represents small ER vesicles generated during cell 
homogenization. 
fractions. These results indicate that after separation from 
CTX-B,  some  CTX-A becomes reduced in the  secretory 
pathway, most likely in the ER.  Clearly, CTX-A existed 
inside the ER vesicles since CTX-A, CTX-A1, and CTX-A2 
remained resistant to digestion with trypsin as long as the 
vesicles  were  not  opened  by  detergents  (Fig.  8).  After 
treatment with Triton X-100,  the  ER marker calreticulin 
and CTX-A1, but little CTX-A and CTX-A2, became di- 
gested  by trypsin.  Since  free  CTX-A  is very sensitive to 
trypsin digestion in vitro (result not shown here), we con- 
clude  that  the  interactions  of CTX-A  and  the  CTX-A2, 
but not of CTX-A1, with components of the ER protected 
them from trypsin digestion. 
In these  experiments, the  cells had been homogenized 
120  min after initiation of CTX uptake, i.e., 60 min later 
than in the experiment shown in Fig. 7 b. This may explain 
why  A2  subunits  could  be  detected  under  nonreducing 
conditions in Fig. 8, but not in Fig. 7 b. 
Time-dependent Increase of 3', 5'-cAMP 
The  concentrations  of  3',  Y-cAMP  did  not  start  to  in- 
crease  until  20  min  after  the  beginning  of  CTX  uptake 
(Fig.  10).  A  strong  increase  began  only after 30  min,  at 
which time the first CTX-A subunits had already left the 
Golgi. These results agree with previous data, which also 
Figure 7.  Distribution of CTX-A and CTX-B after iodixanol gra- 
dient centrifugation. Distribution of CTX subunits after CTX up- 
take for 15 min (a) or 60 rain (b and c). The initial CTX concen- 
tration was 0.5 ixg/ml. Vero cells were homogenized 15 min after 
initiation of CTX uptake. The 3,000-g supernatant was prepared, 
loaded onto an iodixanol gradient, and centrifuged as described 
in Fig. 6. The fractions were diluted, spun at 100,000 g for 60 min, 
and the sediments were analyzed by SDS-PAGE and immuno- 
blotting using the CTX-A2-specific antibody (a and b) or a CTX- 
B-specific antibody (c). The samples in a  and b were processed 
by nonreducing SDS-PAGE without heat treatment of the Laemrnli 
mix; the sample in c was heated and developed by electrophoresis 
under reducing conditions. Note that at the early time point (a) 
under the condition of nonreducing electrophoresis of nonheated 
samples, undissociated CTX could be observed in the first frac- 
tions of the gradient, which had disappeared at the  later time 
point (60 rain, b). 
The Journal  of Cell Biology,  Volume 133, 1996  784 Figure 8. Trypsin resistance  of CTX-A in  the  ER.  Vero cells 
were treated with CTX as described in Fig. 7, except that the cells 
were homogenized 120 min instead of 60 min after the initiation 
of CTX uptake. The gradient fraction with the highest content of 
calreticulin was diluted, and the vesicles were sedimented by cen- 
trifugation  at  100,000 g  for 60 min.  The  sediment  was  resus- 
pended and divided into three equal portions. The first portion 
was directly developed by SDS-PAGE under reducing conditions 
(lane A), the second was first treated with trypsin (lane B), and 
the third (lane C) was first treated with Triton X-100 followed by 
trypsin treatment. The positions of calreticulin (60 kD), CTX-A 
(28.5 kD), CTX-A1 (23 kD), and CTX-A2 (5.5 kD) have been 
marked. Note that calreticulin and CTX-A1 became digested af- 
ter treatment with Triton X-100, whereas CTX-A and CTX-A2 
remained  almost resistant  to the action of trypsin, even in the 
presence of Triton X-100. 
showed  a  delayed  response  of  3',5'-cAMP  levels  after 
CTX  application  (Orlandi  et  al.,  1993;  Nambiar  et  al., 
1993). 
Effects of  Nocodazol on Retrograde  Transport of the 
CTX-A Subunit 
Nocodazol was applied at a time point (30 min) when most 
of the CTX had accumulated in Golgi compartments (see 
Fig. 3). After 20 min of nocodazol treatment (50 min after 
the initiation  of CTX internalization),  intact microtubules 
had disappeared  (Fig. 11, a  and c), and the compact Golgi 
structure  (as indicated  by the distribution  of ERD2)  had 
undergone  fragmentation  to  smaller  vesicular  structures 
dispersed  throughout  the cells  (Fig.  11, b  and d).  At this 
time point, CTX-A was largely found in fragmented struc- 
tures similar to ERD2 (Fig. 11, f-h). 90 min after the initi- 
ation of CTX uptake (60 min after the addition of nocoda- 
zol),  some  CTX-A  still  colocalized  with  the  fragmented 
Golgi although the majority of CTX-A appeared in punc- 
tuated structures distributed  throughout the cell (Figs. 11, 
i and j). In summary, these results show that nocodazol in- 
hibits the transport of CTX-A out of the Golgi, but is un- 
able  to completely block its  exit from this  compartment. 
Apparently,  the  effective  translocation  of  CTX-A  from 
the  ERD2-positive  (Golgi)  compartment  to  the  ER  re- 
quires intact microtubuli. This would be in line with previ- 
ous data of Lippincott-Schwartz et al. (1990), who demon- 
Figure 9.  Formation of CTX-A1 and CTX-A2 in the ER. Vero 
cells were incubated with CTX as described in Fig. 7. 30 min (b) 
and 90 min (c) after initiation of CTX, uptake cells were homoge- 
nized as in Fig.  7, except that the homogenizing medium con- 
tained 5 mM NEM. The homogenate was spun at 3,000 g, and the 
supernatant was analyzed by iodixanol gradient centrifugation as 
described in Figs. 5-7. The fractions from the iodixanol gradient 
were diluted and spun at 100,000 g for i  h. The sediments were 
suspended in Laemmli mix without heating and were analyzed by 
nonreducing SDS-PAGE and immunoblotting using an antibody 
against calreticulin  (a)  or an antibody against  CTX-A that re- 
acted with CTX-A, CTX-A1, and CTX-A2 (b and c). Note the 
appearance of some calreticulin together with some CTX-A1 and 
CTX-A2 in the lighter fractions resulting from breakage of ER 
into smaller vesicles. 
strated  the involvement of microtubules  in the brefeldin 
A-induced "backtransport"  of Golgi enzymes to the ER, 
as well as the further dependence of this phenomenon on 
kinesin (Lippincott-Schwartz et al., 1995). 
Effects of Nocodazol on the Level of 3', 5'cAMP 
Nocodazol given 30 min after the initiation of CTX uptake 
led to a significant delay of cAMP increase at 40 rain (Fig. 
12).  After 90 min, however, cAMP levels again achieved 
similar  levels  as  those  measured  in  cells  that  were  not 
treated  with  nocodazol. This  agrees  well with  the immu- 
nofluorescence results  (Fig.  11), which show that the de- 
struction  of microtubules  delays the transport  of CTX-A 
out of the Golgi-like structures,  but that  CTX-A eventu- 
ally leaves  these  structures  and  arrives  in  more reticular 
compartments (Fig. 11, i and j). 
Discussion 
The approach used here permits the monitoring of the in- 
tracellular  transport  of CTX.  This  was possible  by intro- 
ducing a  short period of CTX internalization  followed by 
more or less complete removal of noninternalized CTX by 
washing  the  cells  with  a  GMl-containing  medium.  Our 
studies do not permit conclusions as to the internalization 
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Figure 10.  Changes of 3', 5'-cAMP levels in Vero cells after treat- 
ment with CrX. Vero cells were treated with 0.1 I*g/ml  CTX. At the 
time points indicated,  ceils were analyzed for 3', 5'-cAMP. Mean 
values  ±  SD from three separate experiments each point mea- 
sured in duplicate. 
mechanism. It has been reported that after binding to the 
ganglioside GM1 in the plasma membrane, CTX becomes 
internalized via noncoated vesicles (Tran et al., 1987), pos- 
sibly via caveoli (Parton, 1994; Parton et al., 1994), but other 
mechanisms have been proposed as well (Sorer and Futer- 
man, 1995). In any case, starting ~15 min after internaliza- 
tion,  CTX-A  and  CTX-B  appear  in  the  TGN  or  Golgi 
compartments, initially as the holotoxin, but later as sepa- 
rated CTX-B and CTX-A, as indicated by measurements 
of fluorescence  resonance  energy  transfer  between  the 
two subunits (Bastiaens et al., 1996).  At later time points 
(60-90 min after the initiation of CTX uptake), a consider- 
able  portion  of  CTX-B  colocalizes  with  the  lysosomal 
marker cathepsin  D  (Fig.  4), indicating  that it had been 
transported from late endosomes or the TGN to the lyso- 
somes.  CTX-B was not  observed in the ER  at any time 
point, in accordance with the data of Sandvig et al. (1994), 
who observed that in A431 cells, CTX-B was taken up by 
endocytosis  and  transported  to  the  Golgi,  but  did  not 
move further to the ER, even under conditions (pretreat- 
ment of the cells with butyric acid) leading to the translo- 
cation of the Shiga toxin B chain to the ER. Since CTX-B 
was labeled with Cy3 in the immunofluorescence studies 
(Fig. 4), even proteolytic fragments of CTX-B reaching the 
intermediate  compartment or the  ER  should  have been 
detected by immunofluorescence. The appearance of CTX 
in the Golgi is in line with previous reports (Janicot and 
Desbuquois,  1987;  Orlandi  et  al.,  1993;  Nambiar  et  al., 
1993), although these studies do not address the question 
of  a  retrograde  transport  of  CTX  subunits  beyond  the 
Golgi. With respect to the fate of CTX-A, it is important 
to note that when CTX clearly had  already reached the 
Golgi (10-20 min), the concentration of cAMP remained 
almost  unchanged.  The  accumulation  of CTX-A  in  the 
Golgi reached its maximum ~,,30 min after the initiation of 
CTX uptake. Thereafter, visible amounts of CTX-A start 
to leave the Golgi and appear in "downstream" compart- 
ments that can be identified as the p53 compartment (in- 
termediate compartment, ERGIC [Schweizer et al., 1988]) 
and  the  ER.  At  the  present  time,  it  remains  unclear 
whether  CTX-A is first transported  to the p53 compart- 
ment and then to the ER, or whether most of the CTX-A 
is transported directly to the ER and a smaller portion to 
the  p53  compartment.  In  any  case,  the  immunofluores- 
cence studies and the gradient centrifugation experiments 
showed that CTX-A reached the ER after 60-90 min. The 
main increase of cAMP levels started after 30 min and did 
not reach its maximum until 90 min. This observation sup- 
ports the assumption that an effective ADP ribosylation of 
Gs~ requires  the  previous transport  of CTX-A from the 
Golgi to downstream compartments, from where it must 
be released into the cytoplasm by mechanisms that are still 
unknown.  The small increase  in cAMP levels at 30 min 
does not conflict with  this view, since  small amounts  of 
CTX-A had reached the ER already at this time point (see 
Fig. 9 b). 
Although  we cannot exclude  that some CTX-A mole- 
cules leave the secretory pathway at the level of the Golgi, 
it appears from our results, including those obtained with 
nocodazol, that transport into the cytoplasm from the down- 
stream compartments (intermediate compartment, ER) is 
more effective. This would also agree with the results that 
show that Pseudomonas exotoxin (Seetharam et al., 1991) 
and ricin A  chain (Sandvig et al., 1994), which are also in- 
ternalized  via  an  endocytic  route,  become  much  more 
toxic if they contain  a  COOH-terminal KDEL sequence 
that  presumably facilitates  their  retrograde  transport  to 
the ER. These data seem to be in conflict with recent data 
of  Cieplak  et  al.  (1995).  These  authors  replaced  the 
COOH-terminal RDEL sequence in Escherichia coli heat- 
labile enterotoxin by RDGL, RDEV, or LEDR, and mea- 
sured the effects of these changes on the cellular elonga- 
tion of CliO-K1 cells or on cAMP levels in Caco-2 cells. 
They concluded that the changes of the COOH-terminal 
tetrapeptide  had no significant  effects on these  parame- 
ters. In the experiments with CliO-K1 cells, however, the 
effect on the morphology was evaluated after the cells had 
been exposed to the toxins for 36--48 h. This time interval 
is certainly too long to evaluate the facilitating effect of 
the RDEL sequence. In the experiments with Caco-2 cells, 
none of the toxin constructs led to a significant increase of 
cAMP until 30 min. At 60 and 120 rain, the wild-type toxin 
clearly induced significantly higher cAMP increases than 
the  mutant  toxins.  Therefore,  a  functional  role  of  the 
COOH-terminal  KDEL sequence  of the  A2  subunit  of 
CTX or the RDEL seqRence of the A  subunit of E.  coli 
heat-labile enterotoxin cannot be excluded on the basis of 
the data presented by Cieplak et al. (1995). 
The protease digestion experiments, as well as the cell 
fractionation experiments in the presence of NEM, show 
that after 90 and 120 rain, not only intact CTX-A, but also 
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the intraceUular transport  of CTX-A. 
Veto cells were treated with CTX as 
described  in Fig. 2.  30 min after the 
initiation of CTX uptake,  nocodazol 
(10  I~g/ml  final  concentration)  was 
added  to the medium, and  the incu- 
bation was continued for another 50 
min.  (a  and  b)  Double  immunoflu- 
orescence  of cells in  the  absence  of 
nocodazol  stained  for  tx-tubulin  and 
ERD2,  respectively.  (c and  d)  Dou- 
ble immunofluorescence of c~-tubulin 
and  ERD2,  respectively,  after  no- 
codazol treatment for 20 min. (e and 
f)  Double  immunofluorescence  of 
calreticulin and CTX-A, respectively, 
after nocodazol treatment for 20 min. 
(g  and  h)  Double  immunofluores- 
cence of ERD2 and CTX-A, respec- 
tively, after nocodazol treatment  for 
20 min. (i and j) Double immunofluo- 
rescence  of ERD2  and  CTX-A,  re- 
spectively, after nocodazol treatment 
for 50 min. Bar, 10 ~m. 
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Figure 12.  Nocodazol  treatment delays  the increase  of 3', 5'- 
cAMP levels. The experiments  were performed as described in 
Fig. 11. At the indicated  times after initiation  of CTX uptake, 
cells were analyzed for 3', 5'-cAMP. Controls were treated only 
with CTX. Mean values +_ SD from three separate experiments 
each point measured in duplicate. 
CTX-A1 and CTX-A2, exist in the ER. The conditions of 
the NEM experiments were such that all reducing metabo- 
lites like reduced glutathione, cysteine, or cysteamine should 
have become alkylated during the homogenization proce- 
dure, so that it seems highly unlikely that CTX-A in the 
secretory pathway had undergone reduction of its disulfide 
bridge caused by the influx of reducing metabolites during 
the  homogenization and  separation  processes.  Therefore, 
the question remains: Where and how does the reduction 
of CTX-A in the secretory pathway occur? The redox con- 
ditions  in  the  ER,  where  disulfide  bridge  formation in 
newly synthetized secretory proteins takes  place, is  not 
very favorable for disulfide bridge reduction (reduced glu- 
tathione/oxidized  glutathione  [GSH/GSSG]  ratio  ~1 
[Hwang et al., 1993]) as compared to the GSH/GSSG ratio 
in the cytoplasm, which amounts to 20-100. Both CTX-A 
as well as CTX-A1 coexist in the ER. It is not yet clear 
whether the toxic effect (ADP ribosylation of Gs~) is ex- 
erted by CTX-A1 generated in the secretory pathway or 
by CTX-A1 produced in the cytoplasm from CTX-A. The 
fact that CTX-A and CTX-A2 are much more resistant to 
trypsin  digestion  in  the  presence  of Triton  X-100  than 
CTX-A1 (Fig. 8) could indicate a preferential interaction 
of CTX-A and CTX-A2 with the phospholipid bilayer of 
the ER. Such an interaction could also mean that CTX-A 
becomes more easily translocated from the ER cisternae 
to the cytosol than does CTX-A1. 
The  time-dependent  transport  of holo-CTX-A  allows 
the study of the backtransport of a KDEL protein from 
the  Golgi to  the  ER  without  the  dramatic  intracellular 
changes observed during overexpression of the KDEL re- 
ceptor (Hsu et al.,  1992; Townsley et al.,  1993), overex- 
pression  of  secretory  proteins  with  a  COOH-terminal 
KDEL sequence (Lewis and Pelham, 1992), or treatment 
with brefeldin A (Hsu et al., 1992). Our approach is similar 
to that used by Miesenb0ck and Rothman (1995) in that it 
uses an indicator molecule applied to the cells from the 
outside  to  study Golgi-ER  backtransport,  but  it  is  less 
complicated. Moreover, it  allows  the  monitoring of the 
transport's time course. This opens the possibility for iden- 
tifying components involved in discrete transport steps, es- 
pecially in combination with microinjection techniques. In 
a first application of the method, we have studied the ef- 
fect of nocodazol on the Golgi-ER backtransport of the 
KDEL protein CTX-A. This effect of nocodazol could be 
discriminated from effects of the drug on earlier transport 
steps by applying it only after CTX-A, the transport indi- 
cator, had reached the Golgi. The results dearly show that 
disruption  of  the  microtubules  inhibits  the  Golgi-ER 
backtransport and delays the increase of cAMP. A partici- 
pation of microtubules in the retrograde transport from 
the Golgi to the ER would be in agreement with earlier 
observations of Lippincott-Schwartz et al. (1990) that were 
obtained in experiments with brefeldin A. 
We have now started to study factors involved in the 
Golgi-ER backtransport of KDEL proteins using the ap- 
proach described here. 
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